BioNTech Begins Trials For Cancer Treatment Based On mRNA

Using the same mRNA technology, the company plans to test a cancer treatment in the UK

The Covid-19 vaccination was developed by the German pharmaceutical company BioNTech.

On Friday, the company announced plans to test a cancer treatment using the same mRNA technology in the UK based on the firm.

Along with a regional office in London, the company will also open a new research and development facility in Cambridge with about 70 people.

He continued on to say that the UK’s successful and speedy production of Covid-19 vaccines demonstrated that pharmaceutical development may be accelerated without forgoing short cuts if everyone works together to achieve the same goal.

The first Covid vaccine to be approved in the West in late 2020, the Pfizer/BioNTec Coronaviruses vaccine, introduced the messenger RNA approach.

Written by Aly Bukshi

The editorial staff at IPIN is a team of news publishing experts led by Aly Bakshi. We publish interesting and informative news/articles all over the world. Our aim is to provide readers with the latest and most up-to-date information possible.